Max Healthcare Institute Limited has informed the stock exchanges that the audio recording of its earnings call is now available for public access. The call was organized on May 22, 2026, to discuss the financial results of the company for the quarter and financial year ended March 31, 2026.

The disclosure was made in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company stated that the recording provides insights into the financial performance for the specified period.

Accessing the Recording

Stakeholders and interested investors can listen to the audio recording by visiting the official website of max healthcare institute . The specific link provided for accessing the earnings call is www.maxhealthcare.in/financials#earnings-call .

Key Details

The following table summarizes the key details regarding the earnings call disclosure:

The communication was addressed to the Listing Departments of the National Stock Exchange of India Limited and BSE Limited. The submission was digitally signed by Dhiraj Aroraa, Senior Vice President - Company Secretary and Compliance Officer of Max Healthcare Institute Limited.

Max Healthcare Institute Limited has reported its financial results for the quarter and year ended March 31, 2026. The company posted a consolidated net profit of 3.4b Rupees for Q4, compared to 3.2b Rupees in the same period last year. Revenue from operations for the quarter stood at 21.4b Rupees versus 19.1b Rupees year-on-year, reflecting steady growth across the hospital network. The board of directors, in its meeting held on May 21, 2026, approved the audited financial results and recommended a final dividend of ₹2 per equity share, subject to shareholder approval. The audio recording of the earnings call held on May 22, 2026, is available on the company's website.

Q4 Financial Performance

The company's operational metrics showed broad-based improvement during the quarter. EBITDA rose to 6b Rupees from 5.1b Rupees in the year-ago period, while EBITDA margin expanded to 28.30% from 26.8%. The following table summarises the key financial highlights for the quarter:

Board Decisions and Dividend

The board approved the audited standalone and consolidated financial results for the fourth quarter and financial year ended March 31, 2026. Based on the profits for FY26, the directors recommended a final dividend of ₹2 per share, representing 20% of the face value of ₹10 each. The dividend will be paid or dispatched within 30 days from the conclusion of the forthcoming Annual General Meeting (AGM).

Strategic Developments

The board approved an investment of approximately ₹1,400 Cr for the construction of Phase-I of Max Super Specialty Hospital on a 5-acre land parcel at Shaheed Path, Lucknow. The new facility is expected to add approximately 712 beds to the network. The project is proposed to be completed within 36 months from the date of approval of drawings by the UP Awas Avam Vikas Parishad. Additionally, the company completed the acquisition of a controlling stake of 58.28% in Kalinga Hospital Ltd. on May 18, 2026, for an aggregate cash consideration of ₹2,980 Cr, making it a subsidiary.

Operational Highlights

Operational bed capacity as at March 31, 2026, stood at 4,966, reflecting an addition of 412 beds in the last 12 months. Average occupancy was 75%, while outpatient consults grew 8% YoY to 9.2 lakhs. The company also reported significant progress in its brownfield expansion projects, including the commissioning of towers at Max Smart, Mohali, and Nanavati-Max.